| AE | adverse event |
| AHCC®® | active hexose correlated compound |
| FFLZ | fucose-containing fraction of G. lucidum |
| HCC | hepatocellular carcinoma |
| HP | hematologic parameters |
| IC50 | half-maximal inhibitory concentration |
| LOA | loss of appetite |
| MDS | myelodys plastic syndromes |
| MM | medicinal mushrooms |
| OS | overall survival |
| QOL | quality of life |
| RCT | randomized, placebo-controlled, double-blind clinical trial |
| ROS | reactive oxygen species |
| SDL | superfine dispersed lentinan |
| SPG | polysaccharide schizophyllan |